Trial site
Next Oncology Dallas
- 14running trials
- 4closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer13 trials
- Pancreatic cancer7 trials
- Colorectal cancer6 trials
- Ovarian cancer5 trials
- Bladder cancer3 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- Head and neck cancer3 trials
- Sarcoma3 trials
- Kidney cancer2 trials
- Liver and biliary tract cancer2 trials
- Mesothelioma2 trials
- and 8 more
- Phase
- Phase 110 trials
- Phase 1/28 trials
- Status
- Recruiting12 trials
- Active, not recruiting2 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Astellas Pharma Inc2 trials
- Gilead Sciences2 trials
- IDEAYA Biosciences2 trials
- Revolution Medicines, Inc.2 trials
- Amgen1 trial
- and 9 more
Running trials
Recruiting
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Recruiting
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Recruiting
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Recruiting
Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recruiting
Active, not recruiting
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer8 recruiting
- Colorectal cancer4 recruiting
- Pancreatic cancer4 recruiting
- Ovarian cancer3 recruiting
- Bladder cancer2 recruiting
- Endometrial cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026